Atul Pande Karuna Therapeutics, Inc. (KRTX) insider trading activity

Atul Pande is of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 990 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $326,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Atul Pande Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2024	SELL Sale (or disposition) back to the issuer	$326,700 $330.0 p/Share	990 Reduced 100.0%	0 Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	-	990 Added 50.0%	990 Common Stock
Feb 01 2022	SELL Open market or private sale	$277,000 $110.8 p/Share	2,500 Reduced 100.0%	0 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Jan 03 2022	SELL Open market or private sale	$326,100 $130.44 p/Share	2,500 Reduced 100.0%	0 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Dec 01 2021	SELL Open market or private sale	$319,325 $127.73 p/Share	2,500 Reduced 100.0%	0 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Nov 01 2021	SELL Open market or private sale	$341,675 $136.67 p/Share	2,500 Reduced 100.0%	0 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Oct 01 2021	SELL Open market or private sale	$301,800 $120.72 p/Share	2,500 Reduced 100.0%	0 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Sep 01 2021	SELL Open market or private sale	$294,550 $117.82 p/Share	2,500 Reduced 100.0%	0 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Aug 02 2021	SELL Open market or private sale	$285,425 $114.17 p/Share	2,500 Reduced 100.0%	0 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Jul 01 2021	SELL Open market or private sale	$281,650 $112.66 p/Share	2,500 Reduced 100.0%	0 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Jun 01 2021	SELL Open market or private sale	$278,600 $111.44 p/Share	2,500 Reduced 100.0%	0 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
May 03 2021	SELL Open market or private sale	$276,525 $110.61 p/Share	2,500 Reduced 100.0%	0 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Apr 01 2021	SELL Open market or private sale	$300,025 $120.01 p/Share	2,500 Reduced 100.0%	0 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$40,000 $16.0 p/Share	2,500 Added 50.0%	2,500 Common Stock
Mar 01 2021	SELL Open market or private sale	$313,575 $125.43 p/Share	2,500 Reduced 100.0%	0 Common Stock

Also insider at

SIOX

Sio Gene Therapies Inc. Healthcare

Director

IMVT

Immunovant, Inc. Healthcare

Director

Atul Pande

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX

Account